We Aim to Dominate the Customization of Hops
The rational, precise improvement of hops is in its infancy. However, it is a significant part of the $500 billion brewing industry and a growing source of medically useful molecules. As a close relative of cannabis/hemp, 22nd Century is well-positioned to directly and seamlessly apply its existing R&D engine to hops, accelerating the development of proprietary specialty hop varieties with valuable traits/IP.
Our precise gene editing and molecular breeding technologies don’t generate GMO products, assuring greater international acceptance of these innovations.